{
  "meta": {
    "title": "19_Anti-Epileptics_I",
    "url": "https://brainandscalpel.vercel.app/19-anti-epileptics-i-13845203.html",
    "scrapedAt": "2025-11-30T12:34:11.116Z"
  },
  "questions": [
    {
      "text": "What is the most important mechanism of antiepileptic activity of phenytoin?",
      "choices": [
        {
          "id": 1,
          "text": "Prolongation of Na+ channel inactivation"
        },
        {
          "id": 2,
          "text": "Reduction in Ca2+ influx"
        },
        {
          "id": 3,
          "text": "Facilitation of GABA response"
        },
        {
          "id": 4,
          "text": "Increasing the K+ influx"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most important mechanism of antiepileptic activity of <strong>phenytoin</strong> is the <strong>prolongation</strong> of <strong>Na<sup>+</sup> ion channel inactivation</strong>. It slows down the rate of recovery of Na+ channels and thus limiting the propagation of the action potential.</p>\n<p>Phenytoin also <strong>inhibits voltage-gated Ca<sup>2+</sup> channels</strong>. This reduces&nbsp;the influx of calcium inside the membrane and&nbsp;reduces the inflow of potassium&nbsp;ions during repolarization.</p>\n<p>At higher or toxic doses, phenytoin facilitates GABA response and inhibits the action of glutamate.</p><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2191",
      "difficulty": "easy"
    },
    {
      "text": "A known case of seizure disorder has been on long-term phenytoin therapy. Which of the following statements about this drug would be incorrect?",
      "choices": [
        {
          "id": 1,
          "text": "Extensively bound to plasma proteins"
        },
        {
          "id": 2,
          "text": "Metabolism follows only zero order kinetics"
        },
        {
          "id": 3,
          "text": "Requires therapeutic drug monitoring"
        },
        {
          "id": 4,
          "text": "Metabolized extensively by the CYP enzymes in the liver"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Phenytoin follows <strong>first-order kinetics</strong> at<strong> lower concentrations&nbsp;</strong>and as the&nbsp;<strong>concentration increases</strong>, the elimination changes to <strong>zero-order kinetics.&nbsp;</strong>The rate of elimination of phenytoin varies with the serum concentration.</p>\n<p>As the blood levels rise, the maximal capacity of the liver to metabolize phenytoin is reached. Thus even a small increase in the dosage can result in disproportionally high plasma levels. Therefore, it requires&nbsp;<strong>therapeutic drug monitoring.&nbsp;</strong></p>\n<p>About&nbsp;<strong>90%</strong> of phenytoin is <strong>bound to plasma proteins,&nbsp;</strong>mainly albumin. Phenytoin is metabolized by the<strong> CYP enzymes</strong> in the liver.</p><hr><h3>Related Pearl: Drugs which need Therapeutic Drug Monitoring (TDM)</h3><p>Drugs with a narrow therapeutic index require therapeutic drug monitoring (TDM).</p>\n<p>The mnemonic \"<strong>DATLAAT MC</strong>\" can be used.</p>\n<ul>\n<li><strong>D</strong>: Digoxin</li>\n<li><strong>A</strong>: Anti-arrhythmic</li>\n<li><strong>T</strong>: Theophylline</li>\n<li><strong>L</strong>: Lithium</li>\n<li><strong>A</strong>: Aminoglycosides</li>\n<li><strong>A</strong>: Anti-epileptics</li>\n<li><strong>T</strong>: Tricyclic antidepressants</li>\n<li><strong>M</strong>: Methotrexate</li>\n<li><strong>C</strong>: Calcineurin inhibitors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2203",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an incorrect statement regarding fosphenytoin?",
      "choices": [
        {
          "id": 1,
          "text": "Water soluble prodrug of phenytoin"
        },
        {
          "id": 2,
          "text": "Fosphenytoin displaces phenytoin from protein-binding sites"
        },
        {
          "id": 3,
          "text": "Causes hyperphosphatemia in renal failure patients"
        },
        {
          "id": 4,
          "text": "ECG monitoring is not required when administering IV"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Fosphenytoin</strong> like phenytoin requires<strong> continuous ECG monitoring</strong> during IV infusion due to the <strong>risk</strong> of <strong>arrhythmias.</strong></p>\n<p>Fosphenytoin is a <strong>water-soluble prodrug</strong> of phenytoin. Fosphenytoin is also extensively protein bound, mainly <strong>albumin</strong>. This binding is saturable and fosphenytoin displaces phenytoin from protein-binding sites.</p>\n<p><strong>Hydrolysis</strong> of fosphenytoin yields phosphate, which increases the <strong>risk </strong>of<strong> hyperphosphatemia</strong> in patients with renal failure.&nbsp;It is contraindicated in patients with sinus bradycardia, sino-atrial block, second and third-degree A-V block.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2204",
      "difficulty": "medium"
    },
    {
      "text": "A patient presenting to the ER with generalized tonic-clonic seizures is started on phenytoin therapy. All of the following adverse effects can be expected in this patient except?<div class='question-desc-html'><ol>\n<li>Lymphadenopathy</li>\n<li>Ataxia</li>\n<li>Hypercalcemia</li>\n<li>Hirsutism</li>\n<li>Hypoglycemia</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3 and 4"
        },
        {
          "id": 2,
          "text": "2 and 4"
        },
        {
          "id": 3,
          "text": "2 only"
        },
        {
          "id": 4,
          "text": "3 and 5"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Phenytoin</strong> causes <strong>hypocalcemia</strong> and <strong>hyperglycemia</strong>.</p>\n<p>It <strong>interferes</strong> with the <strong>metabolism</strong> of <strong>vitamin D</strong> and intestinal <strong>calcium absorption</strong> and results in hypocalcemia.&nbsp;Hyperglycemia and glycosuria can be seen due to the <strong>inhibition</strong> of <strong>insulin</strong> secretion.</p>\n<p>Long-term usage of phenytoin can also cause cutaneous <strong>pseudolymphoma</strong> which is mainly T-cell predominant.<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601451/\" target=\"_blank\" rel=\"noopener\"></a></p><hr><h3>Related Pearl: Adverse effects of Phenytoin</h3><div>Phenytoin adverse effects - Most of them<strong> start with &ldquo;H&rdquo;</strong></div>\n<div>&nbsp;</div>\n<ul>\n<li><strong>H</strong>yperplasia of gums</li>\n<li><strong>H</strong>irsutism</li>\n<li><strong>H</strong>ypersensitivity reactions: rashes, lymphadenopathy</li>\n<li><strong>H</strong>yperglycemia</li>\n<li><strong>H</strong>ypocalcemia and osteomalacia</li>\n<li><strong>H</strong>allucinations and behavioral abnormalities</li>\n<li><strong>H</strong>epatotoxicity</li>\n<li>Fetal <strong>H</strong>ydantoin Syndrome</li>\n<li>Cerebellar and vestibular symptoms: ataxia, nystagmus</li>\n<li><strong>H</strong>ypotension, purple glove syndrome and arrhythmias on IV use</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2193",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following features would you not expect to find in a baby born to a woman on phenytoin therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Digital hypoplasia"
        },
        {
          "id": 2,
          "text": "Gum hyperplasia"
        },
        {
          "id": 3,
          "text": "Microcephaly"
        },
        {
          "id": 4,
          "text": "Cleft lip"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The newborn baby is unlikely to have gum hyperplasia. A baby&nbsp;born to a pregnant mother who was on<strong>&nbsp;phenytoin</strong>&nbsp;therapy will be suffering from <strong>fetal</strong> <strong>hydantoin syndrome</strong>.</p>\n<p>Features of fetal hydantoin syndrome are:</p>\n<ul>\n<li>Microcephaly</li>\n<li>Digital hypoplasia</li>\n<li>Cleft lip/ cleft palate</li>\n</ul>\n<p><strong>Gum hyperplasia</strong> is the most common adverse effect of phenytoin in children and young adolescents on <strong>chronic use</strong>.<label class=\"ng-binding label label-success\"></label></p><hr><h3>Related Pearl: Adverse effects of Phenytoin</h3><div>Phenytoin adverse effects - Most of them<strong> start with &ldquo;H&rdquo;</strong></div>\n<div>&nbsp;</div>\n<ul>\n<li><strong>H</strong>yperplasia of gums</li>\n<li><strong>H</strong>irsutism</li>\n<li><strong>H</strong>ypersensitivity reactions: rashes, lymphadenopathy</li>\n<li><strong>H</strong>yperglycemia</li>\n<li><strong>H</strong>ypocalcemia and osteomalacia</li>\n<li><strong>H</strong>allucinations and behavioral abnormalities</li>\n<li><strong>H</strong>epatotoxicity</li>\n<li>Fetal <strong>H</strong>ydantoin Syndrome</li>\n<li>Cerebellar and vestibular symptoms: ataxia, nystagmus</li>\n<li><strong>H</strong>ypotension, purple glove syndrome and arrhythmias on IV use</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2202",
      "difficulty": "medium"
    },
    {
      "text": "A patient with recent-onset primary generalized epilepsy develops a skin reaction due to phenytoin sodium. What is the most appropriate course of action?",
      "choices": [
        {
          "id": 1,
          "text": "Switch to clonazepam"
        },
        {
          "id": 2,
          "text": "Stop and restart phenytoin sodium after two weeks"
        },
        {
          "id": 3,
          "text": "Switch to sodium valproate"
        },
        {
          "id": 4,
          "text": "Switch to ethosuximide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Hypersensitivity reaction</strong> to<strong> phenytoin&nbsp;</strong>warrants <strong>discontinuation</strong> of the drug.&nbsp;<strong>Switching</strong> to <strong>sodium valproate</strong> is the most appropriate course of action for this patient.&nbsp;</p>\n<p><strong>Sodium valproate</strong> is one of the first-line agents indicated for<strong> GTCS. Clonazepam</strong> and <strong>ethosuximide</strong> are primarily used in <strong>absence seizures</strong> and are not indicated for GTCS.&nbsp;</p>\n<p>Clonazepam is indicated as <strong>adjunctive therapy</strong> in the absence seizures when first-line agents (ethosuximide, sodium valproate, lamotrigine) fail to control the seizures adequately.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2205",
      "difficulty": "medium"
    },
    {
      "text": "A 51-year-old male complains of severe, sharp, piercing intermittent electrical shock-like pain sensation on the left side of his face. The pain was triggered by talking, washing his face, eating, and brushing his teeth. Which of the following drugs is most effective to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Phenytoin"
        },
        {
          "id": 2,
          "text": "Carbamazepine"
        },
        {
          "id": 3,
          "text": "Sodium valproate"
        },
        {
          "id": 4,
          "text": "Lamotrigine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features in this patient are suggestive of a diagnosis of <strong>trigeminal neuralgia</strong> and <strong>carbamazepine</strong> is the most effective agent for its treatment.&nbsp;&nbsp;</p>\n<p>If carbamazepine is ineffective, then second-line<strong>&nbsp;</strong>agents like <strong>lamotrigine</strong> and <strong>phenytoin</strong> are used.</p>\n<p>Sodium valproate although effective for trigeminal neuralgia lacks enough evidence for use.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2213",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is true about carbamazepine?",
      "choices": [
        {
          "id": 1,
          "text": "It is indicated in focal seizures with impaired awareness"
        },
        {
          "id": 2,
          "text": "It is an enzyme inhibitor"
        },
        {
          "id": 3,
          "text": "It causes hypernatremia"
        },
        {
          "id": 4,
          "text": "It is the drug of choice for status epilepticus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Carbamazepine</strong> is indicated in <strong>focal seizures</strong> with<strong> impaired awareness.</strong></p>\n<p>Carbamazepine is an antiepileptic drug that acts by <strong>prolonging</strong> the <strong>inactivated</strong> state of the <strong>Na+ channel</strong> similar to phenytoin. It is used in:</p>\n<ul>\n<li>Focal seizures with impaired awareness</li>\n<li>Focal seizures with intact awareness</li>\n<li>Generalized tonic-clonic seizures</li>\n<li>Trigeminal and related neuralgias</li>\n<li>Manic depressive psychosis.</li>\n</ul>\n<p>Option B: Carbamazepine is an <strong>enzyme inducer</strong>. It is a substrate as well as an inducer of CYP3A4 and CYP2C9.</p>\n<p>Option C: Carbamazepine causes <strong>hyponatremia</strong> and not hypernatremia. Other side effects of carbamazepine include <strong>agranulocytosis</strong> or<strong> aplastic anemia,&nbsp;</strong>hepatotoxicity, water retention and hyponatremia (by potentiating ADH action ), and dose-related neurotoxicity.</p>\n<p>Option D:&nbsp;It is <strong>not</strong> <strong>used</strong> in status epilepticus. <strong>Lorazepam</strong> is the drug of choice for <strong>status epilepticus</strong>.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2217",
      "difficulty": "medium"
    },
    {
      "text": "If carbamazepine is added to ongoing valproate therapy, what adverse effect is risked?",
      "choices": [
        {
          "id": 1,
          "text": "Pancreatitis"
        },
        {
          "id": 2,
          "text": "Thrombocytopenia"
        },
        {
          "id": 3,
          "text": "Hepatotoxicity"
        },
        {
          "id": 4,
          "text": "Hyperammonemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>If <strong>carbamazepine</strong> is added to ongoing <strong>valproate</strong> therapy, it can result in <strong>hepatotoxicity</strong>.</p>\n<p>A combination of valproate and carbamazepine increases hepatotoxicity. Valproic acid may inhibit carbamazepine clearance and increase steady-state carbamazepine blood levels.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7027",
      "difficulty": "medium"
    },
    {
      "text": "In patients recieving carbamazepine, which of the following idiosyncratic reactions are not expected to occur?",
      "choices": [
        {
          "id": 1,
          "text": "Rash"
        },
        {
          "id": 2,
          "text": "Agranulocytosis"
        },
        {
          "id": 3,
          "text": "Peripheral neuropathy"
        },
        {
          "id": 4,
          "text": "Steven Johnson syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Peripheral neuropathy&nbsp;</strong>is not an idiosyncratic reaction that can occur after <strong>carbamazepine</strong> use<strong>.</strong> It is a&nbsp;<strong>dose-dependent</strong> CNS adverse effect. It can be minimized by gradually increasing the dose from initiation or reducing the maintenance dose.</p>\n<p><strong>Idiosyncratic reactions</strong> are hypersensitivity reactions like:</p>\n<ul>\n<li>Rash</li>\n<li>Steven-Johnson syndrome</li>\n<li>Eosinophilia</li>\n<li>Lymphadenopathy.</li>\n<li>Diplopia</li>\n</ul>\n<p>Serious hematological toxicity includes aplastic anemia and agranulocytosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1573",
      "difficulty": "medium"
    },
    {
      "text": "A 70-year-old man is on carbamazepine therapy. Which of the following is expected to occur in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Hypernatremia"
        },
        {
          "id": 2,
          "text": "Hyponatremia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypokalemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Carbamazepine</strong> is expected to cause&nbsp;<strong>hyponatremia </strong>in this patient.</p>\n<p>Carbamazepine potentiates the action of antidiuretic hormone (<strong>ADH</strong>). It can result in&nbsp;<strong>water retention</strong> with <strong>decreased osmolarity</strong> and <strong>hyponatremia,</strong> especially in<strong> elderly</strong> patients with cardiac disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2214",
      "difficulty": "easy"
    },
    {
      "text": "An 8-year-old child diagnosed to have focal seizures was initiated on oxcarbazepine. Which of the following would be incorrect regarding the agent being used?",
      "choices": [
        {
          "id": 1,
          "text": "Keto analog of carbamazepine"
        },
        {
          "id": 2,
          "text": "Enzyme induction potency is less when compared to carbamazepine"
        },
        {
          "id": 3,
          "text": "Metabolised by glucuronide conjugation"
        },
        {
          "id": 4,
          "text": "Hyponatremia risk is less when compared to carbamazepine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The risk of <strong>hyponatremia </strong>with <strong>oxcarbazepine</strong> is <strong>higher</strong> when compared to carbamazepine.&nbsp;</p>\n<p>Option A: Oxcarbazepine is a <strong>keto analog</strong> of carbamazepine. It is a prodrug. The mechanism of action of oxcarbazepine is by <strong>blocking</strong> voltage-gated <strong>sodium channels</strong> (same as carbamazepine).</p>\n<p>Option C: Active form is metabolized by <strong>glucuronide conjugation</strong>.</p>\n<p>Option B: Oxcarbazepine does not cause auto-induction of metabolizing enzymes. It can induce CYP enzymes but less potent when compared to carbamazepine.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2221",
      "difficulty": "medium"
    },
    {
      "text": "A neonate diagnosed with rhabdomyosarcoma was started on vincristine, cyclophosphamide, and cisplatin. A week after initiation of treatment, the baby had multiple episodes of seizures, refractory to diazepam and lidocaine. Workup revealed an elevated ADH level and euvolemic hyponatremia. Which of the following drugs can be used to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Phenytoin"
        },
        {
          "id": 3,
          "text": "Oxcarbazepine"
        },
        {
          "id": 4,
          "text": "Phenobarbital"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>refractory seizures</strong> induced by <strong>hyponatremia</strong>&nbsp;caused by&nbsp;<strong>SIADH</strong> (due to anticancer drugs). <strong>Phenytoin</strong> is used to treat this patient. It is known to <strong>decrease ADH secretion</strong> and stop seizures by<strong> correcting</strong>&nbsp;severe <strong>hyponatremia.</strong></p>\n<p>Options A and C: Carbamazepine and oxcarbazepine <strong>increase</strong> the antidiuretic hormone (<strong>ADH</strong>) levels. This leads to increased sensitivity of renal tubules to ADH levels and hyponatremia. Carbamazepine cannot be used in SIADH because of its antidiuretic effects.</p>\n<p>Option D: Phenobarbital does not affect&nbsp;ADH secretion or action and thus will be ineffective in stopping the seizures.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2227",
      "difficulty": "hard"
    },
    {
      "text": "A 5th-grade student, after receiving multiple complaints from teachers at school for repeated episodes of inattention was brought to the OPD. The mother gave a history that her child had brief spells of staring associated with lip-smacking movements. Which anti-epileptic drug is the most effective for this child?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Ethosuximide"
        },
        {
          "id": 3,
          "text": "Phenytoin"
        },
        {
          "id": 4,
          "text": "Gabapentin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical features are suggestive of <strong>absence seizures</strong> and <strong>ethosuximide</strong> is the most effective agent for this condition.</p>\n<p>First-line drugs in:</p>\n<ul>\n<li>Typical absence seizures: Ethosuximide (<strong>drug of choice</strong>), valproate, lamotrigine</li>\n<li>Atypical absence seizures: Sodium valproate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2235",
      "difficulty": "easy"
    },
    {
      "text": "A child with absence seizures improves after being treated with ethosuximide. Which of the following is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibits L type Ca2+ channels"
        },
        {
          "id": 2,
          "text": "Inhibits  N type Ca2+ channels"
        },
        {
          "id": 3,
          "text": "Inhibits T type Ca2+ channels"
        },
        {
          "id": 4,
          "text": "Inhibits R type Ca2+ channels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The mechanism of action of <strong>ethosuximide</strong> is by<strong> inhibition of T-type Ca<sup>2+</sup> </strong>channels in <strong>thalamic neurons</strong> at clinically relevant concentrations.</p>\n<p>It also affects&nbsp;other ion channels affected include voltage-gated sodium channels and potassium channels.</p><hr><h3>Related Pearl: Types of calcium channels and their blockers</h3><table>\n<tbody>\n<tr>\n<td><strong>Type&nbsp;of Calcium Channel</strong></td>\n<td><strong>Blockers</strong></td>\n</tr>\n<tr>\n<td>L type</td>\n<td>Verapamil, diltiazem, dihydropyridines</td>\n</tr>\n<tr>\n<td>T type</td>\n<td>Flunarizine, ethosuximide, mibefradil</td>\n</tr>\n<tr>\n<td>N type</td>\n<td>Gabapentin, ziconotide</td>\n</tr>\n<tr>\n<td>P/Q type</td>\n<td>Omega agatoxin IVa</td>\n</tr>\n<tr>\n<td>R type</td>\n<td>SNX-482, Omega agatoxin IIIa</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2233",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old child is brought to the OPD with a history of vacant stares lasting for about half a minute. The EEG shows a characteristic 3 Hz spike and wave pattern. Which of the following drugs can be used for this condition?<div class='question-desc-html'><ol>\n<li>Carbamazepine</li>\n<li>Valproate</li>\n<li>Ethosuximide</li>\n<li>Gabapentin</li>\n<li>Pregabalin</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 5"
        },
        {
          "id": 2,
          "text": "2 and 3"
        },
        {
          "id": 3,
          "text": "2 only"
        },
        {
          "id": 4,
          "text": "3, 4 and 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>absence seizures</strong>. <strong>Ethosuximide</strong> and <strong>valproate</strong> are the first-line drugs in this condition.</p>\n<p>Absence seizures are characterized by <strong>sudden</strong>, brief <strong>lapses</strong> of <strong>consciousness</strong> without loss of postural control. There is no postictal confusion. The following subtle motor signs may accompany the episodes</p>\n<ul>\n<li>Rapid blinking of the eyelids</li>\n<li>Chewing movements</li>\n<li>Small-amplitude clonic movements of the hands</li>\n</ul>\n<p><strong>Hyperventilation</strong> has a tendency to <strong>provoke</strong> absence seizures. First-line drugs include:</p>\n<ul>\n<li>Typical absence seizures: Ethosuximide (<strong>drug of choice</strong>), valproate, lamotrigine</li>\n<li>Atypical absence seizures: Valproate</li>\n</ul><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6675",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not an enzyme inducer?",
      "choices": [
        {
          "id": 1,
          "text": "Phenytoin"
        },
        {
          "id": 2,
          "text": "Phenobarbital"
        },
        {
          "id": 3,
          "text": "Carbamazepine"
        },
        {
          "id": 4,
          "text": "Sodium valproate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Sodium valproate</strong> is not an enzyme inducer. It is <strong>metabolized by CYP2C9/19</strong> and is an <strong>inhibitor of CYP2C9</strong>.</p>\n<p>Phenytoin, phenobarbital, and carbamazepine are inducers of CYP and UGT enzymes.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2245",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not the mechanism of action of sodium valproate?",
      "choices": [
        {
          "id": 1,
          "text": "Prolongation of Na+ channel inactivation"
        },
        {
          "id": 2,
          "text": "Inhibition of T type Ca2+ channels"
        },
        {
          "id": 3,
          "text": "Inhibition of GABA transaminase"
        },
        {
          "id": 4,
          "text": "Inhibition of GABA transporter"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Sodium valproate has no action on the GABA transporter.</p>\n<p><strong>Mechanism</strong> <strong>of action</strong> of <strong>sodium valproate:</strong></p>\n<ul>\n<li>Prolongation of sodium channel inactivation</li>\n<li>Inhibition of T-type Ca<sup>2+</sup> channels</li>\n<li>Inhibition of GABA transaminase</li>\n<li>Increases GABA synthesis from glutamic acid.</li>\n</ul><hr><h3>Related Pearl: Mechanism of action of common anti-epileptics</h3><p>Mechanism of action of some common antiepileptics:</p>\n<table>\n<tbody>\n<tr>\n<td>Mechanism of action</td>\n<td>Antiepileptics</td>\n</tr>\n<tr>\n<td>Sodium channel blockers</td>\n<td>\n<ul>\n<li>Phenytoin</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Eslicarbazepine</li>\n<li>Lamotrigine &nbsp; &nbsp;&nbsp;</li>\n<li>Topiramate &nbsp; &nbsp; &nbsp;</li>\n<li>Felbamate</li>\n<li>Valproate</li>\n<li>Rufinamide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Calcium-channel blockers</td>\n<td>\n<ul>\n<li>Valproate</li>\n<li>Lamotrigine &nbsp;&nbsp;</li>\n<li>Ethosuximide</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA<sub>A&nbsp;</sub>receptor modulators</td>\n<td>\n<ul>\n<li>Benzodiazepine</li>\n<li>Phenobarbital</li>\n<li>Felbamate</li>\n<li>Primidone</li>\n<li>Topiramate</li>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine</li>\n<li>Stiripentol</li>\n<li>Clobazam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GABA uptake inhibitors</td>\n<td>\n<ul>\n<li>Tiagabine</li>\n<li>Vigabatrin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Synaptic vesicle glycoprotein 2A(SV2A) inhibitors</td>\n<td>\n<ul>\n<li>Levetiracetam</li>\n<li>Brivaracetam</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>NMDA receptor antagonist</td>\n<td>\n<ul>\n<li>Felbamate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>AMPA/Kainate receptor antagonist</td>\n<td>\n<ul>\n<li>Phenobarbital</li>\n<li>Topiramate</li>\n<li>Perampanel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HCN channel activity enhancers</td>\n<td>\n<ul>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Inhibitors of brain carbonic anhydrase</td>\n<td>\n<ul>\n<li>Acetazolamide</li>\n<li>Zonisamide</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Potassium-channel openers</td>\n<td>\n<ul>\n<li>Retigabine</li>\n<li>Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2238",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following are not adverse effects of sodium valproate?",
      "choices": [
        {
          "id": 1,
          "text": "Weight gain"
        },
        {
          "id": 2,
          "text": "Alopecia"
        },
        {
          "id": 3,
          "text": "Liver damage"
        },
        {
          "id": 4,
          "text": "Osteomalacia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Osteomalacia is not an adverse effect of sodium valproate.</p>\n<p>The <strong>side effects</strong> of valproate (mnemonic: <strong>VALPROATE</strong>)</p>\n<ul>\n<li><strong>V</strong>omiting</li>\n<li><strong>A</strong>lopecia</li>\n<li><strong>L</strong>iver toxicity</li>\n<li><strong>P</strong>ancreatitis</li>\n<li><strong>R</strong>ash</li>\n<li><strong>O</strong>besity</li>\n<li><strong>A</strong>norexia</li>\n<li><strong>T</strong>eratogenicity (most common: spina bifida), thrombocytopenia, tremors&nbsp;</li>\n<li><strong>E</strong>dema</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2244",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following antiepileptic drugs does not cause fulminant hepatitis as a serious complication?",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Felbamate"
        },
        {
          "id": 3,
          "text": "Phenytoin"
        },
        {
          "id": 4,
          "text": "Vigabatrin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Vigabatrin</strong> is not associated with fulminant hepatitis. It is largely <strong>excreted unchanged</strong> in urine <strong>without</strong> undergoing any <strong>hepatic metabolism.</strong></p>\n<p>Sodium valproate, felbamate and phenytoin are associated with<strong> fulminant hepatitis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2241",
      "difficulty": "medium"
    },
    {
      "text": "A 23-year-old female patient is admitted to the neurology ward for evaluation of GTCS. She reports that she has been on oral contraceptive pills for the past 6 months. Which of the following drugs would you prescribe to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Phenobarbital"
        },
        {
          "id": 3,
          "text": "Valproate"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Valproate</strong> is the drug used for this patient as it <strong>does not cause contraceptive failure.</strong></p>\n<p>Valproate is an enzyme inhibitor and it <strong>inhibits</strong> the <strong>degradation</strong> of <strong>OCPs.</strong> OCPs thus have a longer duration of action and less incidence of contraceptive failure with valproate.</p>\n<p>However, other antiepileptic drugs like carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, topiramate are <strong>enzyme inducers</strong>. They cause <strong>increased degradation</strong> of <strong>OCPs</strong> and hence lead to<strong> contraceptive failure</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0943",
      "difficulty": "easy"
    },
    {
      "text": "A 16-year-old patient was brought to the ER with bilateral jerking movements of arms. EEG revealed diffuse, symmetric, bilateral 4-6 Hz polyspike and wave discharges with a frontocentral predominance. What is the most appropriate drug for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Lamotrigine"
        },
        {
          "id": 2,
          "text": "Levetiracetam"
        },
        {
          "id": 3,
          "text": "Topiramate"
        },
        {
          "id": 4,
          "text": "Sodium valproate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical features and EEG findings are suggestive of <strong>juvenile myoclonic epilepsy.</strong>&nbsp;The most appropriate drug for management is <strong>s</strong><strong>odium valproate.&nbsp;</strong></p>\n<p>In patients with myoclonic seizures which are refractory to valproate, clonazepam or clobazam may be added.</p><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2231",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old man visits the neurology OPD with complaints of tremors in both his hands which improve on alcohol intake. On examination, there is a significant worsening of tremors towards the end of finger-to-nose testing and head-nodding movements. Which antiepileptic is approved for use in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Phenobarbital"
        },
        {
          "id": 2,
          "text": "Phenytoin"
        },
        {
          "id": 3,
          "text": "Primidone"
        },
        {
          "id": 4,
          "text": "Valproate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p class=\"p1\">The clinical features are suggestive of a diagnosis of <strong>essential tremors</strong> in this patient. <strong>P</strong><strong>rimidone</strong> is considered to be the first-line therapy for the same along with <strong>propranolol.</strong>&nbsp;</p>\n<p class=\"p1\"><strong>Bilateral, symmetric</strong> <strong>tremors</strong> involving the <strong>hands</strong> associated with head nodding (<strong>titubation</strong>) and <strong>worsening</strong> of tremors <strong>towards</strong> the <strong>end</strong> of <strong>goal-directed movements</strong> such as drinking from a glass or finger-to-nose testing is suggestive of essential tremors.</p>\n<p class=\"p1\"><strong>Primidone</strong> is a barbiturate and functions as a <strong>GABA enhancer</strong>. It is an enzyme inducer. It is used in the treatment of generalized tonic-clonic seizures and partial seizures.</p>\n<p class=\"p1\">It has side effects like sedation, ataxia, and hyperactivity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2190",
      "difficulty": "hard"
    },
    {
      "text": "Pseudolymphoma may occur in patients on long-term therapy with:",
      "choices": [
        {
          "id": 1,
          "text": "Carbamazepine"
        },
        {
          "id": 2,
          "text": "Phenobarbital"
        },
        {
          "id": 3,
          "text": "Phenytoin"
        },
        {
          "id": 4,
          "text": "Primidone"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Phenytoin</strong> on long-term use can result in <strong>pseudolymphoma</strong>.</p>\n<p>This lymphadenopathy can be difficult to distinguish from malignant lymphoma. Although some studies suggest a causal relationship between phenytoin use and Hodgkin&rsquo;s disease, the data are far from conclusive. Almost all lesions are benign and termed as <strong>pseudolymphoma.</strong></p><hr><h3>Related Pearl: Adverse effects of Phenytoin</h3><div>Phenytoin adverse effects - Most of them<strong> start with &ldquo;H&rdquo;</strong></div>\n<div>&nbsp;</div>\n<ul>\n<li><strong>H</strong>yperplasia of gums</li>\n<li><strong>H</strong>irsutism</li>\n<li><strong>H</strong>ypersensitivity reactions: rashes, lymphadenopathy</li>\n<li><strong>H</strong>yperglycemia</li>\n<li><strong>H</strong>ypocalcemia and osteomalacia</li>\n<li><strong>H</strong>allucinations and behavioral abnormalities</li>\n<li><strong>H</strong>epatotoxicity</li>\n<li>Fetal <strong>H</strong>ydantoin Syndrome</li>\n<li>Cerebellar and vestibular symptoms: ataxia, nystagmus</li>\n<li><strong>H</strong>ypotension, purple glove syndrome and arrhythmias on IV use</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2210",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common adverse effect of phenytoin in children and young adolescents on chronic use?",
      "choices": [
        {
          "id": 1,
          "text": "Hirsutism"
        },
        {
          "id": 2,
          "text": "Osteomalacia"
        },
        {
          "id": 3,
          "text": "Gingival hyperplasia"
        },
        {
          "id": 4,
          "text": "Megaloblastic anemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Gingival hyperplasia</strong> occurs in patients on <strong>chronic phenytoin therapy</strong>. It is the <strong>most common manifestation</strong> in children and young adolescents.</p>\n<p>Gingival hyperplasia due to phenytoin therapy occurs due to tissue overgrowth secondary to <strong>altered collagen metabolism.</strong> The toothless portion of gums is not involved. It does not warrant discontinuation of the drug. It can be <strong>minimized</strong> by maintaining <strong>good oral hygiene.</strong></p><hr><h3>Related Pearl: Adverse effects of Phenytoin</h3><div>Phenytoin adverse effects - Most of them<strong> start with &ldquo;H&rdquo;</strong></div>\n<div>&nbsp;</div>\n<ul>\n<li><strong>H</strong>yperplasia of gums</li>\n<li><strong>H</strong>irsutism</li>\n<li><strong>H</strong>ypersensitivity reactions: rashes, lymphadenopathy</li>\n<li><strong>H</strong>yperglycemia</li>\n<li><strong>H</strong>ypocalcemia and osteomalacia</li>\n<li><strong>H</strong>allucinations and behavioral abnormalities</li>\n<li><strong>H</strong>epatotoxicity</li>\n<li>Fetal <strong>H</strong>ydantoin Syndrome</li>\n<li>Cerebellar and vestibular symptoms: ataxia, nystagmus</li>\n<li><strong>H</strong>ypotension, purple glove syndrome and arrhythmias on IV use</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2207",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a carbamazepine analogue that has an advantage of once daily dosing?",
      "choices": [
        {
          "id": 1,
          "text": "Oxcarbezepine"
        },
        {
          "id": 2,
          "text": "Eslicarbazepine acetate"
        },
        {
          "id": 3,
          "text": "Dacarbazine"
        },
        {
          "id": 4,
          "text": "Licarbazepine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Eslicarbazepine acetate</strong> is an analog of carbamazepine that has the advantage of <strong>once-daily</strong> dosing. It is a <strong>prodrug</strong> and is rapidly converted to active <strong>licarbazepine</strong>.</p>\n<p><strong>Oxcarbazepine</strong> is an analog of carbamazepine that is also converted to licarbazepine. Oxcarbazepine does not have the advantage of once-daily dosing like eslicarbazepine acetate.</p>\n<p><strong>Dacarbazine</strong> is not a carbamazepine analog like the other drugs and is a <strong>chemotherapy</strong> medication used in the treatment of <strong>melanoma</strong> and <strong>Hodgkin's lymphoma.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2223",
      "difficulty": "medium"
    },
    {
      "text": "A patient with a history of mitral stenosis presents with the given intractable finding that is refractory to conventional therapy.  What is the drug of choice?",
      "choices": [
        {
          "id": 1,
          "text": "Probenecid"
        },
        {
          "id": 2,
          "text": "Diazepam"
        },
        {
          "id": 3,
          "text": "Haloperidol"
        },
        {
          "id": 4,
          "text": "Sodium valproate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The drug used for <strong>refractory intractable rheumatic chorea</strong> is <strong>sodium valproate,&nbsp;</strong>as it doesn't have extrapyramidal side effects.&nbsp;</p>\n<p>Sydenham's chorea&nbsp;is characterized by <strong>involuntary, purposeless, jerky movements</strong> which mainly affect the&nbsp;<strong>head&nbsp;</strong>and<strong>&nbsp;upper limbs</strong>. In the tongue, it is visible as the characteristic darting movements.</p>\n<p>Medications used to treat Sydenham chorea are:</p>\n<ul>\n<li><strong>Mild</strong> cases - Providing a <strong>calm</strong> environment.</li>\n<li><strong>Severe</strong> cases:\n<ul>\n<li>Dopamine antagonists - haloperidol, pimozide</li>\n<li>Antiepileptic medications - <strong>sodium valproate,&nbsp;</strong>carbamazepine.&nbsp;&nbsp;</li>\n</ul>\n</li>\n<li>Severe, refractory cases - Steroids (thought to be immune-mediated)</li>\n<li>IV immunoglobulins, plasmapheresis - limited studies, decreased efficacy (not currently recommended)</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b859810aab194066b796468d2d827abb.GIF"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1031",
      "difficulty": "medium"
    },
    {
      "text": "A 10-year-old child is brought to the OPD with a history of vacant stares lasting for about half a minute. The EEG shows <3 Hz spike and wave pattern. The first-line drug for the management of this condition is:",
      "choices": [
        {
          "id": 1,
          "text": "Sodium valproate"
        },
        {
          "id": 2,
          "text": "Lamotrigine"
        },
        {
          "id": 3,
          "text": "Levitiracetam"
        },
        {
          "id": 4,
          "text": "Felbamate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and&nbsp;<strong>&lt;3 Hz</strong> spike and wave pattern on EEG is suggestive of <strong>atypical</strong>&nbsp;<strong>absence seizures</strong>. The <strong>first-line&nbsp;</strong><strong>drug</strong> in the treatment of atypical&nbsp;absence seizures is <strong>sodium valproate</strong>.&nbsp;</p>\n<p>Symmetric <strong>3 Hz</strong> spike and wave pattern on EEG is seen in<strong> typical absence seizures</strong>. First-line drugs in its treatment include:</p>\n<ul>\n<li>Ethosuximide (<strong>drug of choice</strong>)</li>\n<li>Valproate</li>\n<li>Lamotrigine</li>\n</ul><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2258",
      "difficulty": "easy"
    },
    {
      "text": "An 18-year-old girl was brought to the OPD with complaints of excessive growth of hair on her face and chest. She is a known case of epilepsy and is on treatment with phenytoin. Which of the following drugs would not cause this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Metoclopramide"
        },
        {
          "id": 2,
          "text": "Methyldopa"
        },
        {
          "id": 3,
          "text": "Amantadine"
        },
        {
          "id": 4,
          "text": "Phenothiazines"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical vignette of excessive hair growth secondary to treatment with <strong>phenytoin</strong> is suggestive of <strong>hirsutism.&nbsp;</strong><strong>Amantadine</strong> does not cause hirsutism or hypertrichosis but its characteristic side effect is <strong>livedo reticularis</strong> (bluish discoloration of the skin).</p>\n<p>Following are the <strong>drugs causing hirsutism</strong>:</p>\n<ul>\n<li>Phenytoin</li>\n<li>Anabolic steroids</li>\n<li>Danazol</li>\n<li>Metoclopramide</li>\n<li>Methyldopa</li>\n<li>Phenothiazines</li>\n<li>Progestins</li>\n<li>Reserpine</li>\n<li>Testosterone</li>\n</ul>\n<p>Following are the <strong>drugs causing hypertrichosis</strong>:</p>\n<ul>\n<li>Cyclosporine</li>\n<li>Diazoxide</li>\n<li>Hydrocortisone</li>\n<li>Minoxidil</li>\n<li>Penicillamine</li>\n<li>Phenytoin</li>\n<li>Psoralens</li>\n<li>Streptomycin</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1257",
      "difficulty": "hard"
    }
  ]
}